Mitosis vs Enzyme — how do they compare? Mitosis trades at Rp396.31 (market cap Rp71,62M, Rp126,71M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and Mitosis's supply is capped (181,3M / 1B MITO (19%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Mitosis for 19 Days and Enzyme for 28 Days on average.
| MITO | MLN | |
|---|---|---|
Market Cap | Rp71,62M | Rp134,13M |
Volume (24h) | Rp126,71M | Rp104,56M |
Circulating Supply | 181,3M / 1B MITO (19%) | 3,3M MLN |
Typical Hold Time | 19 Days | 28 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →